Skip to content

Glaukos GKOS Finance Lease, Principal Payments

Finance Lease, Principal Payments at other companies

Boston Scientific logo
Boston ScientificBSX
$0-100%

Other financials

Income statement

See full
Revenue$150.6M+41.2%
Gross profit$117.2M+42.4%
Operating income-$19.9M+4.0%
Net income-$19.8M-9.0%
EPS (diluted)-$0.34-6.3%

Balance sheet

See full
Cash & equivalents$104.2M-8.8%
Total debt$105.9M-1.7%
Total equity$670.9M-12.2%
Total assets$893.3M-7.5%

Cash flow

See full
Operating cash flow-$12.5M+32.4%
CapEx$4.0M+104%
Free cash flow-$16.5M+19.4%

Valuation

See full
Market cap$7.68B+12.3%
Enterprise value$7.68B+12.5%
P/S13.9×-3.0×

Profitability

See full
Gross margin78.1%+2.3pp
Operating margin-36.1%+24.3pp
Net margin-34.3%+4.8pp
FCF margin-13.2%-3.9pp

Returns & leverage

See full
Return on equity-26.4%+11.1pp
Debt / equity0.2×0.0×
Current ratio5.4×-1.1×

Where this comes from

Reported directly by Glaukos in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeasePrincipalPayments.

The official record: Glaukos’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Glaukos's finance lease, principal payments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Glaukos's finance lease, principal payments?
Glaukos (GKOS) reported finance lease, principal payments of $304K in Q1 2026.
How has Glaukos's finance lease, principal payments changed year-over-year?
Glaukos's finance lease, principal payments increased by 22.6% year-over-year, from $248K to $304K.
What is the long-term trend for Glaukos's finance lease, principal payments?
Over 4 years (2021 to 2025), Glaukos's finance lease, principal payments has grown at a 14.2% compound annual growth rate (CAGR), from $659K to $1.12M.